Japanese firm adds ex-Norvartis and Alnylam in-house counsel

Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Wilson Sonsini senior counsel moves to a rival firm

6 February 2026 The New York-based partner will advise biotech, pharma, and technology clients on patent prosecution, IP strategy and venture-backed transactions.

Careers

Nine-partner litigation team leaves Winston & Strawn

5 February 2026 The trial group, which brings “exceptional litigation talent”, joins larger firm in Texas and Washington, DC, coinciding with the announcement of the Winston Taylor merger.

Careers

Squire Patton Boggs brings in tech and data expert as Ireland practice lead

4 February 2026 The new hire, who has clients in pharma and medical devices and diagnostics, will lead the Dublin office's IP & Technology practice.